The Ketamine Conference A Molecular Masterclass

Website https://go.evvnt.com/664028-2?pid=4800 | Edit Freely

Category Education, Health, Business , Economics

Deadline: August 20, 2020 | Date: August 21, 2020-August 22, 2020

Venue/Country: Online, U.K.

Updated: 2020-08-20 13:33:19 (GMT+9)

Call For Papers - CFP

About this Event

THE KETAMINE CONFERENCE

MOLECULAR MASTERCLASSES BY MICRODOSE

Deep dives into key psychedelic compounds.

21st and 22nd August 2020

Ketamine is creating new pathways to pain management and better mental health. We present a complete exploration of ketamine at the intersection of clinical care, research and investment, featuring the world’s top researchers, clinicians, companies, advocates and experts.

Discover the potential of ketamine and NMDA receptor antagonists in the treatment of key mental and physical conditions through keynote presentations, expert panels, interactive discussions and collaboration. This two-day conference brings together experts in the field to discuss the very latest science, health care innovation and business opportunities in this rapidly growing field.

Sponsors

Bexson Biomedical - developing therapies for chronic and acute pain management.

The Conscious Fund - investing in early-stage ventures in plant-based medicine.

Microdose - psychedelic insights, events, podcasts, news and market intelligence.

Speakers

Jeffrey Becker, MD

Martha B. Koo, MD

Steve Mandel, MD

Veronika Gold, MFT

Wes Ryan, MD

Anthony El Chibani

David Feifel

Gregg Peterson

Sandhya Prashad

Stephen Parker

Steve Best

Our Mission

Connect leaders in ketamine science, delivery, and training with clinicians, business leaders and capital.

Translate the science behind ketamine and NMDA Receptor based interventions.

Illustrate the dynamic and nuanced nature of this medication in medical treatment.

Provide perspective on the realities of working in this rapidly evolving space.

Identify pitfalls, medical concerns, delivery gaps and medical/legal issues in the field.

Review markets, investment cases and value propositions for ketamine-based therapies.

Showcase the leading enterprises within the ketamine sector worldwide.

CONFERENCE TIMES and FORMAT

Panels and keynotes will run for 45 minutes, with a 15 minute QandA session afterwards. The conference will begin at 17:00 (GMT) / 12:00(EST) / 09:00 (PST) each day. You will be sent login and platform details with your ticket.

The whole conference will be recorded and will be available to all ticket holders to enable attendees to make the most of the experience.

Speakers will be confirmed and added to each track. We are expecting more than 40 leading lights from across the ketamine ecosystem to present.

URL:

Tickets https://go.evvnt.com/664028-0?pid=4800

Prices:

Standard Ticket: GBP 65.0

Investor VIP Ticket : GBP 216.0

Speakers: Steve Mandel, MD, Wes Ryan, MD, David Feifel, Stephen Parker, Steve Best, Jon Wolfe (Austin Ketamine Clinic), Martha B. Koo, MD (Neuro Wellness Spa), Jeffrey Becker, MD (Bexson Biomedical), Sandhya Prashad, MD (Houston Ketamine Therapeutics), Veronika Gold, MFT (Polaris Insight Center), Rupert McShane, MD (University of Oxford), Gregg Peterson (Bexson Biomedical), Anthony El Chibani (Ketamine Media)

Time: 4:00 pm - 11:00 pm